MNMD
Mind Medicine Inc
NASDAQ: MNMD · HEALTHCARE · BIOTECHNOLOGY
$15.02
+1.01% today
Updated 2026-01-14
Market cap
$1.46B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.98
Dividend yield
—
52W range
$5 – $15
Volume
1.9M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$28.67
+90.88%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-29.57M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-93.04M | $-56.80M | $-95.73M | $-108.68M | $-67.27M |
| EPS | — | — | — | — | $-1.98 |
| Free cash flow | $-45.82M | $-50.14M | $-64.36M | $-79.13M | $-29.57M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Mind Medicine Inc trades at $15.02. Our Smart Value Score of 20/100 indicates the stock is weak.
Frequently asked questions
What is Mind Medicine Inc's stock price?
Mind Medicine Inc (MNMD) trades at $15.02.
Is Mind Medicine Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Mind Medicine Inc (MNMD)?
The analyst target price is $28.67, representing +90.9% upside from the current price of $15.02.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-0.86%
Beta2.62
50D MA$13.48
200D MA$10.29
Shares out0.10B
Float0.10B
Short ratio—
Avg volume1.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—